pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
immuneering PRESS RELEASE ARCHIVE
Jul 29, 2021
Immuneering Announces Pricing of Upsized Initial Public Offering
Jul 14, 2021
Immuneering Expands Board of Directors with Appointment of Ann E. Berman
Apr 27, 2021
Immuneering Expands Board of Directors with Addition of Senior Biotechnology Executive Laurie Keating
Apr 6, 2021
Immuneering Appoints Biren Amin, M.B.A., as Chief Financial Officer
Mar 25, 2021
Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer
Aug 11, 2020
Immuneering to Present at Oppenheimer's Private Life Sciences Company Call Series
Jul 28, 2020
Immuneering to Present at the Inaugural LifeSci Partners Private Company Virtual Summer Symposium
Jun 25, 2020
Immuneering Enters Collaboration with Astex Pharmaceuticals to Identify Novel Therapeutic Targets in Central Nervous System Disorder Using Disease Cancelling Technology
Jan 22, 2020
Immuneering Raises $20 Million in Oversubscribed Series A Funding
Jan 9, 2020
Immuneering Strengthens Executive Team With Appointment of Howard L. Kaufman, M.D., as Head of Research and Development
Dec 19, 2019
Immuneering Appoints Scott Barrett, M.D., as Chief Medical Officer
Dec 4, 2019
Immuneering to Present at the 12th International Conference on Cachexia, Sarcopenia and Muscle Wasting
Aug 3, 2015
Teva and Immuneering Announce Teva’s Purchase of 51% Equity Share of Genomic-Analysis Company
Jan 29, 2014
Immuneering Corporation Expands Alliance with Bristol-Myers Squibb
